IRIX
IRIDEX Corporation
There isn't enough reported data to score IRIX yet.
IRIX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Unavailable |
IRIX's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
IRIX PE Valuation
IRIX has no meaningful PE right now: it lost money over the past year.
IRIX Forward outlook
There aren't enough analyst estimates for IRIX to show an outlook.
IRIX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.20 | +$0.13 |
| Q1 2026 | -$0.19 | +$0.24 |
| Q4 2025 | -$0.26 | +$0.28 |
| Q3 2025 | -$0.30 | +$0.37 |
| Q2 2025 | -$0.33 | +$0.33 |
| Q1 2025 | -$0.43 | +$0.24 |
| Q4 2024 | -$0.54 | +$0.05 |
| Q3 2024 | -$0.67 | -$0.19 |
IRIX is still losing money, but far less than before: $0.20 per share over the past year, against $0.73 at its worst in late 2019.
IRIX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $12.6M | -7.4% |
| Q1 2026 | $11.8M | -0.8% |
| Q4 2025 | $14.7M | +16% |
| Q3 2025 | $12.5M | +7.8% |
| Q2 2025 | $13.6M | +7.4% |
| Q1 2025 | $11.9M | +1.1% |
| Q4 2024 | $12.7M | +1.9% |
| Q3 2024 | $11.6M | -9.9% |
IRIX's revenue fell from its 2022 peak and has held roughly level since: $13M last quarter, down 7.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -8.2% | -1.3 points |
| Q1 2026 | -2.8% | -1 points |
| Q4 2025 | -0.1% | +3.9 points |
| Q3 2025 | -11% | +4.8 points |
| Q2 2025 | -6.9% | +14 points |
| Q1 2025 | -1.7% | +26 points |
| Q4 2024 | -4% | +21 points |
| Q3 2024 | -16% | -3 points |
IRIX's operating margin was −8.2% last quarter, down 1.3 points from the same quarter a year ago.
IRIX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $124K | +$534K |
| Q1 2026 | -$1.4M | -$276K |
| Q4 2025 | $483K | +$1.7M |
| Q3 2025 | -$1.2M | +$1.9M |
| Q2 2025 | -$410K | +$916K |
| Q1 2025 | -$1.2M | +$491K |
| Q4 2024 | -$1.2M | -$300K |
| Q3 2024 | -$3.1M | -$1.2M |
IRIX has burned cash in almost every quarter: −$2M over the past year, against −$6M the year before.
IRIX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +107K shares |
| 1 year | +3.7% | +625K shares |
| 3 years | +8.6% | +1.4M shares |
| 5 years | +6.8% | +1.1M shares |
| Available history | +27% | +3.6M shares |
IRIX has 17M diluted shares, up 3.7% from a year ago.
IRIX Net Leverage
IRIX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
IRIX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.1 | Neutral |
| Stochastic | 20.8 | Neutral |
IRIX's weekly RSI is 41 (neutral) and its Stochastic is 21 (neutral).
IRIX PE vs Healthcare Sector
IRIX has no meaningful PE right now: it lost money over the past year.
IRIX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.72 | 1.4% below |
| 20 week MA | $0.79 | 10% below |
| 50 week MA | $1.02 | 30% below |
| 100 week MA | $1.11 | 36% below |
| 200 week MA | $1.68 | 58% below |
IRIX is in a downtrend: it's below all five of its weekly moving averages, and 58% below its 200-week average.
IRIX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.35 | $1.94 | -17% |
| 2021 | $1.94 | $6.22 | +221% |
| 2022 | $6.22 | $2.11 | -66% |
| 2023 | $2.11 | $2.81 | +33% |
| 2024 | $2.81 | $1.67 | -41% |
| 2025 | $1.67 | $1.23 | -26% |
| 2026 YTD | $1.23 | $0.71 | -42% |
IRIX's yearly returns have swung widely, from +221% in 2021 to −66% in 2022. It's down 42% so far in 2026.